Teva finds positive results in advanced trials for asthma drug – Reuters


Globes

Teva finds positive results in advanced trials for asthma drug
Reuters
Reslizumab, an investigational antibody, showed statistically significant reductions in the frequency of asthma exacerbations – episodes of progressively worsening shortness of breath, coughing, wheezing, and chest tightness – compared to patients
Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical StudiesRTT News
Teva reports positive Phase III asthma drug resultsGlobes

all 4 news articles »

View full post on asthma – Google News

Teva Gets Positive CHMP Opinion For DuoResp Spiromax To Treat Asthma And … – RTT News

Teva Gets Positive CHMP Opinion For DuoResp Spiromax To Treat Asthma And
RTT News
DuoResp Spiromax is a new multi-dose dry-powder inhaler with a combination of budesonide, an inhaled corticosteroid to treat the underlying inflammation in asthma and COPD, and formoterol fumarate dihydrate, a rapid-acting and long-lasting beta2 
EU Agency backs respiratory drugs for approvalReuters UK
EMA Backs Generic Versions of AstraZeneca's SymbicortBloomberg

all 7 news articles »

View full post on asthma – Google News

Teva Gets Positive CHMP Opinion For DuoResp Spiromax To Treat Asthma And … – NASDAQ

Teva Gets Positive CHMP Opinion For DuoResp Spiromax To Treat Asthma And
NASDAQ
DuoResp Spiromax is a new multi-dose dry-powder inhaler with a combination of budesonide, an inhaled corticosteroid to treat the underlying inflammation in asthma and COPD, and formoterol fumarate dihydrate, a rapid-acting and long-lasting beta2 
UPDATE 1-EU Agency backs respiratory drugs for approvalReuters
EMA Backs Generic Versions of AstraZeneca's SymbicortBloomberg

all 7 news articles »

View full post on asthma – Google News

Israel : TEVA bags approval from FDA to market generic asthma treatment … – Equities.com


MedPage Today

Israel : TEVA bags approval from FDA to market generic asthma treatment
Equities.com
US Food and Drug Administration (FDA) have given its approval to Teva Pharmaceutical Industries Ltd. for generic versions of asthma and allergies treatment Singulair in adults and children. Made by Merck & Co., brand Singulair has $5 billion in annual
New generic Singulair could save asthma sufferers big bucksConsumerReports.org
Generic Singulair ApprovedWebMD
FDA approves generic versions of asthma, allergy drugDrug Store News
MedPage Today –RTT News –Jerusalem Post
all 52 news articles »

View full post on asthma – Google News